Clinical data | |
---|---|
Trade names | Stenobolone, Anatrofin |
Other names | RS-2106; S-3760; 2-Methyl-4,5α-dihydro-δ1-testosterone 17β-acetate; 2-Methyl-δ1-DHT 17β-acetate; 2-Methyl-5α-androst-1-en-17β-ol-3-one 17β-acetate |
Routes of administration | Intramuscular injection |
Drug class | Androgen; Anabolic steroid; Androgen ester |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C22H32O3 |
Molar mass | 344.495 g·mol−1 |
3D model (JSmol) | |
| |
|
Stenbolone acetate (USAN ) (brand name Stenobolone, Anatrofin; former developmental code names RS-2106, S-3760), also known as 2-methyl-4,5α-dihydro-δ1-testosterone 17β-acetate (2-methyl-δ1-DHT 17β-acetate) or as 2-methyl-5α-androst-1-en-17β-ol-3-one 17β-acetate, is a synthetic, injected anabolic–androgenic steroid (AAS) and derivative of dihydrotestosterone (DHT) which has been marketed in Spain.[1][2][3]
It is the C17β acetate ester of stenbolone, which is structurally related to 1-testosterone (Δ1-DHT; dihydroboldenone) and to drostanolone (2α-methyl-DHT).[1][2][3]